BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 31

• 

  Deals

  Why Intercept Pharma Just Became an Even More Attractive Takeover Target

  May 31, 2016

   · 

  3 min read
• 

  Policy

  Merck & Co., Pfizer and Others Join Forces to Fight California Drug Price Control Ballot Initiative

  May 31, 2016

   · 

  3 min read
• 

  FDA

  FDA Approves Biogen and AbbVie’s Once-Monthly MS Drug Zinbryta

  May 31, 2016

   · 

  2 min read
• Policy

  Teva Gains Recommendation For Approval From FDA Advisory Committees For VANTRELA ER (Hydrocodone Bitartrate) Extended-Release Tablets CII Formulated With Proprietary Abuse Deterrence Technology

  May 31, 2016

   · 

  7 min read
• FDA

  Intercept Pharma’s Liver Drug Wins Accelerated Approval by the FDA

  May 31, 2016

   · 

  13 min read
• Job Trends

  Bay Area’s Booming Mission Bay Life Sciences Community

  May 31, 2016

   · 

  1 min read
• Policy

  Lawsuit Claims Gilead Could Have Created Safer HIV Drug Sooner But Didn’t Due to Profits

  May 31, 2016

   · 

  1 min read
• Business

  Boehringer Ingelheim, Inventiva Ink EUR170 Million Idiopathic Pulmonary Fibrosis Deal

  May 31, 2016

   · 

  3 min read
• Policy

  FDA Wants Teva to Re-Analyze the Blood Levels of Certain Metabolites of Huntington Disease Drug

  May 31, 2016

   · 

  7 min read
• Biotech Bay

  Bay Area VC Firm 5AM Ventures Rakes in $285 Million Life Science Fund

  May 31, 2016

   · 

  1 min read